Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Flowers

Showing results (151-160 of 247) with videos related to

Pageof 25
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantationMarcello Rotta, Barry E Storer, Rainer Storb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantationPaul J Martin, George W Counts, Frederick R Appelbaum, et al.
Bone Marrow Transplantation|December 3, 2003
Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantationJ Storek, M A Dawson, L C-L Lim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2020
Age and gender differences in financial distress among hematopoietic cell transplant survivorsSalene M W Jones, Jean C Yi, Heather S L Jim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 2, 2019
Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 StudyEdmund K Waller, David Miklos, Corey Cutler, et al.
Infection Control and Hospital Epidemiology|June 6, 2009
Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborativeHoward E Jeffries, Wilbert Mason, Melanie Brewer, et al.
Haematologica|April 22, 2011
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemiaRon Ram, Rainer Storb, Brenda M Sandmaier, et al.
Bone Marrow Transplantation|April 21, 2009
Therapy with mycophenolate mofetil for refractory acute and chronic GVHDT Furlong, P Martin, M E D Flowers, et al.
Cancer|January 10, 2018
Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantationKasey J Leger, K Scott Baker, Kara L Cushing-Haugen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2011
Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantationRon Ram, Ted A Gooley, David G Maloney, et al.
Pageof 25

Showing results (151-160 of 247) with videos related to

Sort By:
Pageof 25
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantationMarcello Rotta, Barry E Storer, Rainer Storb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantationPaul J Martin, George W Counts, Frederick R Appelbaum, et al.
Bone Marrow Transplantation|December 3, 2003
Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantationJ Storek, M A Dawson, L C-L Lim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2020
Age and gender differences in financial distress among hematopoietic cell transplant survivorsSalene M W Jones, Jean C Yi, Heather S L Jim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 2, 2019
Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 StudyEdmund K Waller, David Miklos, Corey Cutler, et al.
Infection Control and Hospital Epidemiology|June 6, 2009
Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborativeHoward E Jeffries, Wilbert Mason, Melanie Brewer, et al.
Haematologica|April 22, 2011
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemiaRon Ram, Rainer Storb, Brenda M Sandmaier, et al.
Bone Marrow Transplantation|April 21, 2009
Therapy with mycophenolate mofetil for refractory acute and chronic GVHDT Furlong, P Martin, M E D Flowers, et al.
Cancer|January 10, 2018
Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantationKasey J Leger, K Scott Baker, Kara L Cushing-Haugen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2011
Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantationRon Ram, Ted A Gooley, David G Maloney, et al.
Pageof 25